NASDAQ : CBUS

Cibus, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 1.35 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 103.18M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Details

NameCibus, Inc.
SectorHealthcare
IndustryBiotechnology
Employees118
Founded2010
Ipo Date2017-07-20
CeoCraig Wichner
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS17166A1016
Cusip17166A101
Cik0001705843
Sic2870
Stock TypeCommon Stock
Share ClassClass A Shares

Key executives

NameTitle
Craig WichnerChief Executive Officer
Dr. Peter R. Beetham B.Sc., Ph.D.Co-Founder, President and Chief Operating Officer
Dr. Gregory F. Gocal Ph.D.Co-Founder, Chief Scientific Officer and Executive Vice President
Rory Balfour Riggs M.B.A.Co-Founder and Director
Jason Stokes Esq., J.D.Chief Administrative Officer, General Counsel and Corporate Secretary
Cornelis Broos M.Sc.Chief Financial Officer
Rosa Cheuk Kim J.D.Senior Vice President of Legal
Dr. Noel Sauer Ph.D.Senior Vice President of Research

Contact

Address6455 Nancy Ridge Drive, San Diego, California 92121, United States
Phone858 450 0008
Websitehttps://www.cibus.com